Monty Silverdale
Monty Silverdale publishes mostly in Neurology, Cellular and Molecular Neuroscience and Neurology, on topics such as Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Botulinum Toxin and Related Neurological Disorders.
- World rank
- #354,183 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #31,388 of 367,258
- Works
- 151
- Citations
- 4.5k
- Citations per work
- 30.1
What does Monty Silverdale research?
Monty Silverdale's work is mostly in Medicine (50%), Neuroscience (14%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7549.8%
- Medicine7549.8%
- Everything else4831.5%
- Life Sciences2818.7%
- 1Neurology46% of their works
- 2Cellular and Molecular Neuroscience6% of their works
- 3Neurology5% of their works
- 4Molecular Biology5% of their works
- 5Physiology3% of their works
- 6Cognitive Neuroscience3% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
- Transcranial Magnetic Stimulation Studies
- Genetic Neurodegenerative Diseases
- Parkinson's Disease and Spinal Disorders
- Advanced Chemical Sensor Technologies
- Neurological and metabolic disorders
Which keywords describe Monty Silverdale's research?
The keywords of their largest research topics: Parkinson's Disease, Neurological Disorders, Mitochondrial Dysfunction, Deep Brain Stimulation, Basal Ganglia, a-Synuclein, Neurodegeneration and Subthalamic Nucleus.
- Hyperglycemia
- Electronic Nose
- Dropped Head Syndrome
- Protein Aggregation
- Transcranial Magnetic Stimulation
- Neurotoxins
- Stroke
- Subthalamic Nucleus
- Neurodegeneration
- Deep Brain Stimulation
- Neurological Disorders
- Parkinson's Disease
- Mitochondrial Dysfunction
- Basal Ganglia
- a-Synuclein
- Treatment-Resistant Depression
- Botulinum Toxin
- Transcranial Direct Current Stimulation
- Huntington's Disease
- Camptocormia
- Breath Analysis
- Chorea
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Parkinson's Disease1773 topics
- Neurological Disorders1133 topics
- Mitochondrial Dysfunction972 topics
- Deep Brain Stimulation942 topics
- Basal Ganglia892 topics
- Neurodegeneration831 topic
- a-Synuclein831 topic
- Subthalamic Nucleus811 topic
- Treatment-Resistant Depression811 topic
- Stroke272 topics
- Botulinum Toxin191 topic
- Neurotoxins191 topic
- Transcranial Direct Current Stimulation171 topic
- Transcranial Magnetic Stimulation171 topic
- Huntington's Disease141 topic
- Protein Aggregation141 topic
- Camptocormia131 topic
- Dropped Head Syndrome131 topic
- Breath Analysis91 topic
- Electronic Nose91 topic
- Chorea81 topic
- Hyperglycemia81 topic
Where does Monty Silverdale work?
Monty Silverdale's main affiliation in the publication record is Salford Royal NHS Foundation Trust, United Kingdom.
How many publications and citations does Monty Silverdale have?
OpenAlex counts 151 works and 4,549 citations for Monty Silverdale, an h-index of 41, ranking #354,183 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Monty Silverdale. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.